Research activity

Here is a list of all the research activity pages:

Generic List

Accessing Social Care – Learning Disabilities (ASC-LD)

Description
The Accessing Social Care – Learning Disabilities team (University of Birmingham) are running a research study, to ask adults with learning disabilities from Black and minority ethnic communities about their views of social care services. The study has been funded by the National Institute for Health Research's School of Social Care Research. The team will be looking for people to take part in our project until Spring 2013.

Accuracy of Bladder Ultrasound Study (BUS) trial

Description
Accuracy of Bladder Ultrasound Study (BUS) trial in Birmingham Clinical Trials Unit

Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome trial 16 (AML16)

Description
Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome trial 16 (AML16) in Birmingham Clinical Trials Unit

AD2000 Trial - A reliable assessment of the efficacy and safety of donepezil and aspirin in Alzheimer's Disease

Description
AD2000 Trial - A reliable assessment of the efficacy and safety of donepezil and aspirin in Alzheimer's Disease.

Adenovirus group

Description
Research page for the adenovirus group, run by Roger Grand and Andy Turnell, School of cancer Sciencesa, College of medical and Dental Sciences, Univesaity of Birmingham.

Advanced Manufacturing Centre - Mechanical Engineering research

Description
The Advanced Manufacturing Centre brings together key research groups and individuals within the Department. It includes: Machining; Process Modelling / Casting; Geometric Modelling; Continuous Improvement / Quality.

Angioplasty and Stent for Renal Artery Lesions trial (ASTRAL)

Description
ASTRAL is a multicentre, randomized, unblinded clinical trial, comparing revascularisation in addition to medical therapy versus medical therapy alone in patients with atherosclerotic renovascular disease (ARVD). The aim of ASTRAL is to assess whether renal arterial revascularisation with balloon angioplasty and/or endovascular stenting can safely prevent progressive renal failure among patients with ARVD. ASTRAL closed to recruitment in October 2007 having recruited 806 patients, and is now in long term follow up until 2017. The trial is managed by the BCTU at the University of Birmingham.
Displaying 1 to 10 of 473
Previous 1 2 3 4 5 Next